Shoucheng's Capital Leap: Zhao Tianyang Drives 2025 Upswing

The year 2025 marks the resurgence of industrial capital focused on long-term value creation. Recently, Shoucheng Holdings (0697.HK) stands out with a multidimensional breakthrough – racking up investment successes, winning multiple institutional and individual awards, executing steady share buybacks, and receiving bullish analyst ratings. The company's long-term roadmap anchored in hard-tech and industrial depth is […]

DDD Securities Lawsuit Filed Against 3D Systems Corporation. Contact the DJS Law Group to Discuss Your Rights

The DJS Law Groupreminds investors of a class action lawsuit against 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD) for violations of securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Shareholderswho purchased the Company's securities betweenAugust 13, 2024 and May 13, 2025, inclusive (the “Class Period”), are encouraged to contact the firm beforeAugust 12, 2025. CASE DETAILS: The

Propel Fuels is Awarded $195 Million Additional Exemplary Damages for Trade Secret Misappropriation by Phillips 66, Bringing Total Award to More Than $833 Million

Kobre & Kim led litigation leading to one of the largest trade secret verdicts in U.S. history. California renewable fuels pioneer Propel Fuels, Inc. (“Propel”) has been awarded $195 million in exemplary damages for trade secret misappropriation by Phillips 66 Company (“Phillips 66”). Together with the jury's $604.9 million award of compensatory damages, and pre-judgment

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

(NYSE:ANRO), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO GlobeNewswire August 01, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE:

Future of India – Forecast to 2035 | MarketsandMarkets(TM)

Future of India – Forecast to 2035 | MarketsandMarkets(TM) GlobeNewswire August 01, 2025 Delray Beach, FL, July 31, 2025 (GLOBE NEWSWIRE) — According to MarketsandMarkets(TM), “Future of India – Forecast to 2035″ offers a comprehensive analysis of the mega trends propelling India's growth by 2035. It also includes an extensive coverage of growth opportunities in

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

(TSX-V:STUD),(Boerse Frankfurt – Freiverkehr:HM40.F),(OTC US:STLNF),(Other OTC:STLNF),(Frankfurt:FE0), NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its news release of July 8th, 2025, the Company provides certain

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture

Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025 (GLOBE NEWSWIRE) — Diplomatic Trade Ltd and Kent Global Support Strategic Stake in Turkish Pharma Group, Plan $300M UAE Biopharma Initiative Cross-border biopharma venture targets UAE facility launch in Q3 2025 and public listing by year-end Diplomatic Trade Ltd, a cross-border trade and investment

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement GlobeNewswire August 01, 2025 NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its news release

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture Cross-border biopharma venture targets $300M IPO valuation and UAE facility launch by Q3 2025 GlobeNewswire August 01, 2025 Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025

Scroll to Top